Skip to main content
915 TLDR
Health
1 read

Study Links Toxic Chemicals to Accelerated Aging in Middle-Aged Men

KVIA••CNN Newsource
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

Read Original

AI Summary

Recent research indicates that exposure to PFAS, commonly known as 'forever chemicals,' may be causing faster aging in men aged 50 to 65. This study, published in the journal Frontiers in Aging, analyzed blood samples from a group of 326 older adults and found significant associations between PFAS levels and epigenetic aging, particularly in men. PFAS are linked to various health issues, including hormone disruption and increased cancer risks. While the findings highlight a potential health concern, experts caution that the study does not prove causation. Individuals are advised to reduce PFAS exposure where possible, such as using certified water filters and minimizing contact with treated materials.

Key Details: • Men aged 50-65 show the strongest links to accelerated aging due to PFAS exposure. • PFAS are found in the blood of approximately 98% of Americans. • Recommendations include using certified water filters and following local water advisories.

environment health research aging chemicals

People & Organizations

US Environmental Protection AgencyAmerican Chemistry CouncilFood Packaging ForumXiangwei LiJane Muncke

Related Articles

KTSM•Apr 25

New Study Reveals Rising Use of Psilocybin Among Americans

A recent study indicates that approximately 8 million Americans have consumed psilocybin, commonly known as 'magic mushrooms,' in the past year. The findings highlight that usage is particularly prevalent among young adults, men, and white individuals. This trend suggests a growing acceptance and potential therapeutic use of psilocybin, prompting clinicians to consider incorporating questions about its use into routine patient assessments. Understanding this shift in substance use is crucial for healthcare providers as they navigate treatment options.

Health
1 min read
KTSM•Apr 24

El Paso to Participate in National Prescription Drug Take Back Day This Saturday

This Saturday, April 25, the U.S. Drug Enforcement Administration (DEA) will conduct its 30th National Prescription Drug Take Back Day, providing a crucial opportunity for residents to safely dispose of unused or expired medications. The event will take place from 10 a.m. to 2 p.m. at nearly 4,200 locations across the country, including several in El Paso. This initiative is vital for preventing drug misuse and protecting the environment. Residents are encouraged to participate and help reduce the risk of prescription drug abuse in the community.

Health
1 min read
KTSM•Apr 24

Severe Health Risk: Flesh-Eating Bacteria Detected in New York Waters

A dangerous strain of flesh-eating bacteria has been identified in the waters of New York, raising significant health concerns. Individuals who contract this infection face a staggering 20% mortality rate within just 48 hours. This alarming statistic underscores the urgency for public awareness and precautionary measures, especially for those engaging in water activities. Residents are advised to stay informed about local water safety and health advisories to mitigate risks associated with this deadly bacteria.

Health
1 min read
KVIA•Apr 24

FDA Fast-Tracks Approval for Psychedelic Drugs in Mental Health Treatment

The FDA has expedited the review process for several psychedelic drugs aimed at treating mental health conditions, including psilocybin for treatment-resistant depression and PTSD. This initiative, part of a pilot program, could significantly reduce the time these treatments take to reach patients. A recent executive order from President Trump mandates the FDA to prioritize these therapies and includes a $50 million investment for state studies on their benefits. As the FDA continues to authorize clinical trials for psychedelics like ibogaine, the potential for these drugs to address the mental health crisis in the U.S. is gaining attention, particularly for veterans and those with severe mental health issues. However, the FDA warns that these substances, classified as Schedule I drugs, will only be available in controlled clinical settings if approved.

Health
1 min read